U016 Lasers & Energy Devices in the Treatment of Acne
DESCRIPTION
Acne vulgaris is the most common skin disorder in Dermatology. Medical therapy is considered first-line in the treatment of all forms of acne, including inflammatory, comedonal and nodulocystic types. Recently, new technology has been developed to address acne. This session will review the published literature on the various lasers and energy devices used in the treatment of acne vulgaris, along with an algorithm that incorporates medical therapies. Safety protocols will be reviewed, including the use of these devices in diverse racial skin types.
LEARNING OBJECTIVES
Discuss the various lasers and energy devices that are available for the treatment of acne.
Choose the appropriate laser or energy device for acne patients with diverse skin types.
Describe an algorithm that incorporates lasers/energy devices with medical therapies for acne patients.
SCHEDULE
3:30 PM
Laser Physics: How to Use New Laser Technology to Treat Acne Patients
Omar Ibrahimi, MD, PhD, FAAD
3:45 PM
Combining Lasers and Energy Devices with Medical Therapies in Acne Management
Valerie D. Callender, MD, FAAD
4:00 PM
Lasers and Energy Devices for Acne Scarring
Girish S. Munavalli, MD, MHS, FAAD
4:15 PM
Questions & Answers
DIRECTOR
Valerie D. Callender, MD, FAAD
SPEAKERS
Omar Ibrahimi, MD, PhD, FAAD
Girish S. Munavalli, MD, MHS, FAAD
DISCLOSURES
Valerie D. Callender, MD, FAAD
Aerolase – Advisory Board(Stock Options), Speaker/Faculty Education(Honoraria); Altree – Stockholder Private Company(Stock Options); Arcutis Biotherapeutics – Speaker(Honoraria); Beiersdorf, Inc. – Speaker(Honoraria); Callender Center for Clinical Research – Founder(No Compensation Received); Eli Lilly – Speaker/Faculty Education(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Elsevier Inc. – Independent Contractor(Honoraria); Incyte – Investigator(Grants/Research Funding); Janssen Biotech – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Consultant(Honoraria), Investigator(Honoraria); La Roche-Posay - L'Oreal Group – Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Prollenium Medical Technologies – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals Inc – Investigator(Grants/Research Funding); Restore Biologics – Advisory Board(Honoraria); Sinclair Pharma – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Speaker(Honoraria); symatese – Investigator(Grants/Research Funding); TEOXANE Laboratories – Investigator(Grants/Research Funding); Unilever – Advisory Board(Honoraria); UpToDate – Other(Patent royalties or other compensation for Intellectual Property Rights); Veradermics – Advisory Board(Honoraria); VeraDermics Inc. – Investigator(Grants/Research Funding); WoltersKluwer Health – Independent Contractor(Patent royalties or other compensation for Intellectual Property Rights);
Omar Ibrahimi, MD, PhD, FAAD
Accure, Inc – Advisory Board(No Compensation Received); Allergan, Inc – Advisory Board(Honoraria); AVAVA, LLC – Investigator(Grants/Research Funding); Cynosure-Lutronic – Consultant (1099 relationship)(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(Honoraria); Quthero, Inc – Consultant (1099 relationship)(Honoraria); Unilever – Stockholder(Stock);
Girish S. Munavalli, MD, MHS, FAAD
AbbVie – Investigator(Grants/Research Funding); Benev – Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Honoraria); Lumenis – Investigator(Equipment); Sofwave – Investigator(Stock Options);